» Articles » PMID: 30226145

Gametocyte Carriage, Antimalarial Use, and Drug Resistance in Cambodia, 2008-2014

Abstract

Gametocytes are the malaria parasite stages responsible for transmission from humans to mosquitoes. Gametocytemia often follows drug treatment, especially as therapies start to fail. We examined gametocyte carriage and drug resistance profiles among 824 persons with uncomplicated malaria in Cambodia to determine whether prevalent drug resistance and antimalarial use has led to a concentration of drug-resistant parasites among gametocyte carriers. Although report of prior antimalarial use increased from 2008 to 2014, the prevalence of study participants presenting with microscopic gametocyte carriage declined. Gametocytemia was more common in those reporting antimalarial use within the past year, and prior antimalarial use was correlated with higher ICs to piperaquine and mefloquine, as well as to increased copy number. However, there was no association between microscopic gametocyte carriage and parasite drug resistance. Thus, we found no evidence that the infectious reservoir, marked by those carrying gametocytes, is enriched with drug-resistant parasites.

Citing Articles

An Ultra-Sensitive Technique: Using -mtCOX1 qPCR to Detect Early Recurrences of in Patients in the Brazilian Amazon.

Barbosa L, da Silva E, de Almeida A, Salazar Y, Siqueira A, Alecrim M Pathogens. 2021; 10(1).

PMID: 33396824 PMC: 7823330. DOI: 10.3390/pathogens10010019.


Artemether-Lumefantrine Efficacy for the Treatment of Uncomplicated Malaria in Choco, Colombia after 8 Years as First-Line Treatment.

Olivera M, Guerra A, Cortes L, Horth R, Padilla J, Novoa J Am J Trop Med Hyg. 2020; 102(5):1056-1063.

PMID: 32100686 PMC: 7204575. DOI: 10.4269/ajtmh.19-0954.


Efficacy and Safety of Pyronaridine-Artesunate plus Single-Dose Primaquine for the Treatment of Malaria in Western Cambodia.

Leang R, Khim N, Chea H, Huy R, Mairet-Khedim M, Mey Bouth D Antimicrob Agents Chemother. 2019; 63(10).

PMID: 31358594 PMC: 6761550. DOI: 10.1128/AAC.01273-19.

References
1.
Ashley E, Dhorda M, Fairhurst R, Amaratunga C, Lim P, Suon S . Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014; 371(5):411-23. PMC: 4143591. DOI: 10.1056/NEJMoa1314981. View

2.
Lon C, Tsuyuoka R, Phanouvong S, Nivanna N, Socheat D, Sokhan C . Counterfeit and substandard antimalarial drugs in Cambodia. Trans R Soc Trop Med Hyg. 2006; 100(11):1019-24. DOI: 10.1016/j.trstmh.2006.01.003. View

3.
Amato R, Lim P, Miotto O, Amaratunga C, Dek D, Pearson R . Genetic markers associated with dihydroartemisinin-piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study. Lancet Infect Dis. 2016; 17(2):164-173. PMC: 5564489. DOI: 10.1016/S1473-3099(16)30409-1. View

4.
Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois A, Khim N . A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2013; 505(7481):50-5. PMC: 5007947. DOI: 10.1038/nature12876. View

5.
. Gametocyte carriage in uncomplicated Plasmodium falciparum malaria following treatment with artemisinin combination therapy: a systematic review and meta-analysis of individual patient data. BMC Med. 2016; 14:79. PMC: 4879753. DOI: 10.1186/s12916-016-0621-7. View